According to Future Market Insights (FMI), the global biosimulation market is expected to witness remarkable growth, driven by increasing investments in pharmaceutical R&D, growing adoption of computational modeling in drug development, rising demand for precision medicine, and expanding use of artificial intelligence in life sciences. The integration of biosimulation platforms across drug...
SPARK Website
عربي